TWD 49.25
(0.72%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 3.91 Billion TWD | 46.8% |
2022 | 2.66 Billion TWD | -12.03% |
2021 | 3.03 Billion TWD | 23.72% |
2020 | 2.45 Billion TWD | 18.84% |
2019 | 2.06 Billion TWD | -9.53% |
2018 | 2.28 Billion TWD | 40.9% |
2017 | 1.61 Billion TWD | 1350.26% |
2016 | -129.5 Million TWD | -105.34% |
2015 | 2.42 Billion TWD | -20.9% |
2014 | 3.06 Billion TWD | 20.89% |
2013 | 2.53 Billion TWD | -23.99% |
2012 | 3.33 Billion TWD | 10.89% |
2011 | 3.01 Billion TWD | 74.7% |
2010 | 1.72 Billion TWD | 36.05% |
2009 | 1.26 Billion TWD | -42.2% |
2008 | 2.19 Billion TWD | -41.85% |
2007 | 3.76 Billion TWD | 3.63% |
2006 | 3.63 Billion TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 324.73 Million TWD | 54.81% |
2024 Q2 | 450.69 Million TWD | 38.79% |
2023 Q4 | 209.76 Million TWD | -65.3% |
2023 FY | 3.91 Billion TWD | 46.8% |
2023 Q1 | 509.02 Million TWD | 3.23% |
2023 Q2 | 2.59 Billion TWD | 409.94% |
2023 Q3 | 604.57 Million TWD | -76.71% |
2022 Q1 | 778.9 Million TWD | 5.13% |
2022 FY | 2.66 Billion TWD | -12.03% |
2022 Q4 | 493.1 Million TWD | -21.55% |
2022 Q3 | 628.53 Million TWD | -18.28% |
2022 Q2 | 769.1 Million TWD | -1.26% |
2021 Q3 | 785.1 Million TWD | 3.26% |
2021 Q2 | 760.32 Million TWD | 1.61% |
2021 FY | 3.03 Billion TWD | 23.72% |
2021 Q1 | 748.29 Million TWD | 106.45% |
2021 Q4 | 740.89 Million TWD | -5.63% |
2020 Q3 | 506.25 Million TWD | 27.19% |
2020 Q4 | 362.46 Million TWD | -28.4% |
2020 Q1 | 1.18 Billion TWD | 128.57% |
2020 Q2 | 398.04 Million TWD | -66.44% |
2020 FY | 2.45 Billion TWD | 18.84% |
2019 Q1 | 551.67 Million TWD | -13.45% |
2019 Q3 | 466.49 Million TWD | -11.46% |
2019 Q4 | 518.92 Million TWD | 11.24% |
2019 FY | 2.06 Billion TWD | -9.53% |
2019 Q2 | 526.86 Million TWD | -4.5% |
2018 Q2 | 647.67 Million TWD | 51.93% |
2018 Q4 | 637.43 Million TWD | 11.85% |
2018 FY | 2.28 Billion TWD | 40.9% |
2018 Q1 | 426.29 Million TWD | 52.65% |
2018 Q3 | 569.91 Million TWD | -12.01% |
2017 Q1 | 507.05 Million TWD | 180.19% |
2017 FY | 1.61 Billion TWD | 1350.26% |
2017 Q4 | 279.25 Million TWD | -22.93% |
2017 Q3 | 362.36 Million TWD | -22.98% |
2017 Q2 | 470.45 Million TWD | -7.22% |
2016 Q1 | 71.02 Million TWD | -93.53% |
2016 FY | -129.5 Million TWD | -105.34% |
2016 Q2 | 282.53 Million TWD | 297.8% |
2016 Q3 | 185.37 Million TWD | -34.39% |
2016 Q4 | -632.27 Million TWD | -441.08% |
2015 Q1 | 47.37 Million TWD | -98.33% |
2015 FY | 2.42 Billion TWD | -20.9% |
2015 Q4 | 1.09 Billion TWD | -4.55% |
2015 Q3 | 1.14 Billion TWD | 760.35% |
2015 Q2 | 133.57 Million TWD | 181.93% |
2014 Q3 | 119.72 Million TWD | 743.91% |
2014 FY | 3.06 Billion TWD | 20.89% |
2014 Q1 | 103.5 Million TWD | 312.83% |
2014 Q2 | 14.18 Million TWD | -86.29% |
2014 Q4 | 2.83 Billion TWD | 2264.51% |
2013 Q3 | 231.64 Million TWD | 853.46% |
2013 Q4 | 25.07 Million TWD | -89.18% |
2013 Q1 | 2.25 Billion TWD | 59.16% |
2013 Q2 | 24.29 Million TWD | -98.92% |
2013 FY | 2.53 Billion TWD | -23.99% |
2012 Q4 | 1.41 Billion TWD | 85.24% |
2012 FY | 3.33 Billion TWD | 10.89% |
2012 Q1 | 517.26 Million TWD | 20.94% |
2012 Q2 | 638.33 Million TWD | 23.41% |
2012 Q3 | 765.55 Million TWD | 19.93% |
2011 Q2 | 801.7 Million TWD | -0.25% |
2011 FY | 3.01 Billion TWD | 74.7% |
2011 Q4 | 427.71 Million TWD | -56.27% |
2011 Q3 | 978.01 Million TWD | 21.99% |
2011 Q1 | 803.72 Million TWD | 0.14% |
2010 FY | 1.72 Billion TWD | 36.05% |
2010 Q4 | 802.62 Million TWD | 197.64% |
2010 Q3 | -822.01 Million TWD | -181.45% |
2010 Q2 | 1 Billion TWD | 37.53% |
2010 Q1 | 733.79 Million TWD | 0.0% |
2009 FY | 1.26 Billion TWD | -42.2% |
2008 FY | 2.19 Billion TWD | -41.85% |
2007 FY | 3.76 Billion TWD | 3.63% |
2006 FY | 3.63 Billion TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Sinon Corporation | 1.05 Billion TWD | -272.233% |
All Cosmos Bio-Tech Holding Corporation | 139.36 Million TWD | -2712.158% |
CH Biotech R&D Co., Ltd. | 463.29 Million TWD | -745.916% |